APA (7th ed.) Citation

Goldvaser, H., Khutsurauli, S., Buchinger, M., Safonov, A., & Grinshpun, A. (2026). Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Cancers, 18(13), 2077. https://doi.org/10.3390/cancers18132077

Chicago Style (17th ed.) Citation

Goldvaser, Hadar, Salome Khutsurauli, Michele Buchinger, Anton Safonov, and Albert Grinshpun. "Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis." Cancers 18, no. 13 (2026): 2077. https://doi.org/10.3390/cancers18132077.

MLA (9th ed.) Citation

Goldvaser, Hadar, et al. "Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis." Cancers, vol. 18, no. 13, 2026, p. 2077, https://doi.org/10.3390/cancers18132077.